News | July 24, 2013

ContextVision Receives Positive Ruling in Patent Litigation

Stockholm District Court ruling makes ContextVision the owner of a 2006 patent registered by Sapheneia

July 24, 2013 — The Stockholm District Court ruled ContextVision is the owner of a patent application filed by Sapheneia in September 2006. The patent application represents the underlying technology across multiple medical imaging modalities. ContextVision proved that the technology within the patent is a result of work the two filing inventors conducted during their time at ContextVision.

According to Swedish law, any invention or patent application filed within six months of employment belongs to the previous employer. In this case, Sapheneia registered the patent application five months after the inventors left ContextVision, making ContextVision the rightful owner of the application.

Sapheneia’s platform, “Clarity Server Solution,” relates to the technology included within the September 2006 patent application. Due to the court’s ruling, ContextVision now owns the patent application.

The main hearing was held in Stockholm, May 27-30, 2013. On July 12, 2013 the Stockholm District Court ruled in favor of ContextVision and declared that ContextVision owns the patent application. Sapheneia was ordered to pay ContextVision’s legal costs during this process, amounting to TSEK 2,940.

For more information: www.contextvision.com

Related Content

Guerbet Partners With Imalogix on Dose Optimization With Artificial Intelligence
News | Radiation Dose Management | August 14, 2018
August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of...
Imalogix Brings Fluoroscopy Capabilities to Radiation Dose Management Platform
Technology | Radiographic Fluoroscopy (RF) | August 06, 2018
Imalogix, a provider of artificial intelligence (AI) process and workflow solutions, announced the availability of the...
Sectra radiation dose monitoring software can help manage radiation dose from multiple medical imaging modalities.
News | Radiation Dose Management | July 25, 2018
July 25, 2018 – Sectra will install its cloud-based,...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
The images (before and after) depict a 50 percent dose reduction in chest X-ray without compromising  image quality.

The images (before) depict a 50 percent dose reduction in chest X-ray without compromising
image quality.

Sponsored Content | Case Study | Radiation Dose Management | July 03, 2018
There are a handful of priorities for radiologists: lowest radiation dosage, highest image quality, optimal workflow,...
3-D Imaging and Computer Modeling Capture Breast Duct Development

An image of a developing mammary duct. Image courtesy of Andrew Ewald.

News | Breast Imaging | June 28, 2018
A team of biologists has joined up with civil engineers to create what is believed to be the first 3-D computer model...
3D Systems Announces On Demand Anatomical Modeling Service
Technology | Medical 3-D Printing | June 18, 2018
3D Systems announced availability of its new On Demand Anatomical Modeling Service. This new service provides a wide...
Technology | Orthopedic Imaging | June 13, 2018
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS...
Overlay Init